Developer docs
API playgroundTry for free, no card

Search company profiles

Varelas S.a. Chemicals And Diagnostics

Full company profile

uuid02locmc

Namestring
Varelas S.a. Chemicals And Diagnostics
Legal namestring
VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά)
Websiteurl
varelas.gr
Company typeenum
Private
Founded yearint
1950
Descriptiontext

VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor of diagnostics reagents, life-science research products, laboratory instrumentation and related laboratory services. It serves clinical diagnostics laboratories and hospitals (public and private), diagnostic centres, universities, research institutes and R&D laboratories in Greece and Cyprus. The company was founded in the early 1950s by pharmacist Nikolaos D. Varelas as N.D. VARELAS S.A. Chemicals & Pharmaceuticals, originally distributing and trading medicines, and later repositioned into diagnostics and life-science research supply. It is an unlisted Greek joint-stock company (Α.Ε.) affiliated with the Galenica Group and employs 11-50 people.

The product portfolio is multi-brand and organised by business sector rather than as a single platform, covering haematology (immunohaematology, special blood transfusion tests, haemostasis, plasma cell dyscrasias), immunology and life-science research (autoimmunity, immunodeficiency, histocompatibility/immunogenetics, cytokines and other research molecules, proteins, molecular biology reagents, microarrays, laboratory consumables), microbiology (infectious immunology, bacteriology, virology, mycology, parasitology, tuberculosis), cytology, molecular diagnostics, hormones, and a broad instrumentation catalogue (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, protein electrophoresis, nucleic acid analysis and extraction, media preparation, immunofluorescence, hybridisation/immunodot, microELISA, sample storage systems). Alongside product sales, the company operates laboratory service lines: oligonucleotide synthesis, sequencing, PCR and thermal cycler validation, molecular testing services, and external quality assessment programmes spanning haematology, immunocytochemistry, immunology, histocompatibility/immunogenetics, clinical chemistry, blood transfusion laboratory practice, microbiology and blood coagulation. The technical substrate is in-house service and logistics infrastructure rather than proprietary technology: an Order Entry and Distribution Centre, an Order Entry/Customer Service Centre at the Kifissia headquarters, a Technical Support Department staffed by specialised scientific personnel, and an in-house Order Entry/Customer Service Centre supported by Galenica Group IT, cloud and hosting affiliates.

Revenue is generated through three streams: transaction revenue from distributing diagnostics reagents, kits and consumables; product-sale revenue from laboratory instrumentation; and professional-services revenue from laboratory/technical services and external quality assessment, supported by pre-, during- and post-sales technical support. Pricing is quote-based and not publicly disclosed - no prices, tiers or discounts are published. Go-to-market is primarily direct: order entry by call centre (info@varelas.gr, +30 210 5281900) and the Kifissia distribution centre, inside and field sales into laboratories, hospitals and research institutions, a representative office serving the Northern Greek market from Thessaloniki, and exclusive distribution partnerships (for example, ABL Diagnostics in Cyprus and Montenegro). Demand generation is supported by co-hosted scientific webinars with product partners (a Binding Site Freelite series on multiple myeloma, nephrology, osteoporosis and neurological disorders), online education, a newsletter service and a bilingual corporate website. No revenue figure is disclosed; the only financial document referenced is a FY2015 statutory financial statements PDF (41st corporate year), and no funding rounds, acquisitions, mergers or listing events are disclosed.

Short descriptiontext

VARELAS S.A. Chemicals & Diagnostics is a Greece- and Cyprus-based distributor of diagnostics reagents, laboratory instrumentation, life-science research products and laboratory services, supplying hospitals, diagnostic laboratories and research institutions with scientific technical support from its Kifissia headquarters.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKifisiá, Greece
HQ citystring
Kifisiá
HQ countrystring
Greece
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostics reagents distribution, laboratory instrumentation supply, life-science research products, external quality assessment programmes, oligonucleotide synthesis services
Industry5 codes
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAHAAAC
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • Medical and Diagnostic Laboratories6215
  • Scientific Research and Development Services5417
SIC code4 codes
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
  • Services-Medical Laboratories8071
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
  • Services-Commercial Physical & Biological Research8731
Product category
Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distribution
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Distribution and sale of diagnostics reagents, kits and consumables
TypeTransaction Fee
Description

Core revenue comes from supplying and distributing high quality, innovative products (diagnostics reagents, immunohaematology, microbiology, molecular diagnostics, life-science research reagents, laboratory consumables) to the Greek health and life-science research market, generating one-time transaction revenue from order fulfilment through the company's Order Entry and Distribution Centre in Kifissia.

varelas.gr
2Instrumentation and equipment sales
TypeHardware Sales
Description

Sale and supply of laboratory instrumentation (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, electrophoresis, hybridisation & immunodot, microELISA, sample storage systems) as a product-sale revenue stream.

varelas.gr
3Laboratory and technical services
TypeProfessional Services
Description

Service revenue from oligonucleotide synthesis, sequencing services, PCR/thermal cycler validation, molecular testing services and external quality assessment programmes, complemented by pre-, during- and post-sales technical support delivered by the Technical Support Department.

varelas.gr
4Pharmaceutical / health product trading (legacy business)
TypeTransaction Fee
Description

Founded in the early 1950s for the distribution and trading of medicines, the company developed rapidly into one of the largest pharmaceutical trading enterprises in Greece; the current entity operates under the Chemicals & Diagnostics name.

varelas.gr
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

VARELAS S.A. is a Greek distributor of diagnostics reagents and kits (haematology, immunohaematology, haemostasis, microbiology, cytology, molecular diagnostics, hormones, life-science research reagents) and laboratory instrumentation, together with related laboratory services including oligonucleotide synthesis, sequencing, PCR/thermal cycler validation, molecular testing and external quality assessment programmes. Products are sourced from third-party manufacturers and supplied to clinical diagnostics laboratories, hospitals and life-science research institutions across Greece and Cyprus through its own Order Entry and Distribution Centre in Kifissia, backed by a scientific technical support department.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Operations spanning more than four decades of continuous development of the Greek health and life-science research market
+1 more record
Product overview1 text field

VARELAS S.A. (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor — not a single unified software product — whose offering is a multi-brand, multi-sector portfolio of diagnostics reagents, life-science research products, laboratory instrumentation and related services, delivered to Greek and Cypriot health and research markets. The portfolio is organised as business-sector product lines rather than a core platform with add-on modules: Haematology (Immunohaematology, Special Blood Transfusion Tests, Haemostasis, Plasma Cell Dyscrasias), Life Science Research (Molecular Biology Reagents, Laboratory Consumables, Cytokines & Other Research Molecules, Microarrays, Oligonucleotide Synthesis Services, Sequencing Services, Sample Storage and Management Systems, PCR Validation), Instrumentation (Nucleic Acid Analysis, Immunodiffusion, Immunofluorescence, Hyperthermia Pump, Gel Documentation, Nucleic Acid Extraction, Automated Blood Culture Systems, Automated ID/AST Systems, Blood Transfusion Lab Instrumentation, Proteins Electrophoresis, Thermal Cyclers, Turbidimeters/Nephelometers, Media Preparation and Dispensing, Haemostasis and Immunohaematology Instrumentation, Vein Detection System, Rapid Infuser, Microarray Platforms, Hybridization & Immunodot, microELISA, Real Time PCR, CLIA), Microbiology (Infectious Immunology, Bacteriology, Virology, Mycology, Parasitology, Tuberculosis), Cytology (Liquid Based Cytology), Molecular Diagnostics (Pathogen Detection, Genetic Abnormalities, Genetic Diseases, Histocompability, Blood Group Typing), Hormones, Molecular Testing Services, Immunology (Autoimmunity, Immunodeficiency Test, Histocompability, Cytokines & Other Research Molecules, Proteins) and External Quality Assessment programmes. These sector lines are complemented by service layers — the Distribution Network and Technical Support functions and an online webinar training series (with Binding Site, featuring the Freelite free light chain kits for multiple myeloma monitoring) — so instrumentation, reagents and consumables are sold together with logistics, training and quality-assessment support rather than as one connected software platform.

Product and service60 records
1Immunohaematology
CategoryDiagnostics product line (haematology)
2Special Blood Transfusion Tests
CategoryDiagnostics product line (haematology)
3Haemostasis
CategoryDiagnostics product line (haematology)
4Plasma Cell Dyscrasias
CategoryDiagnostics product line (haematology)
5Molecular Biology Reagents
CategoryLife-science research product line
6Laboratory Consumables
CategoryLife-science research product line
7Cytokines & Other Research Molecules
CategoryLife-science research product line
8Proteins
CategoryLife-science research product line
9Microarrays
CategoryLife-science research product line
10Oligonucleotide Synthesis Services
CategoryLaboratory service
11Sequencing Services
CategoryLaboratory service
12Sample Storage and Management Systems
CategoryLaboratory instrumentation / systems
13PCR Validation
CategoryLaboratory service
14Thermal Cycler Validation
CategoryLaboratory service
15Nucleic Acid Analysis
CategoryLaboratory instrumentation
16Immunodiffusion
CategoryLaboratory instrumentation
17Immunofluorescence
CategoryLaboratory instrumentation
18Hyperthermia Pump
CategoryLaboratory instrumentation
19Gel Documentation
CategoryLaboratory instrumentation
20Nucleic Acid Extraction
CategoryLaboratory instrumentation
21Automated Blood Culture Systems
CategoryLaboratory instrumentation
22Automated ID/AST Systems
CategoryLaboratory instrumentation
23Blood Transfusion Lab Instrumentation
CategoryLaboratory instrumentation
24Proteins Electrophoresis
CategoryLaboratory instrumentation
25Thermal Cyclers
CategoryLaboratory instrumentation
26Turbidimeters / Nephelometers
CategoryLaboratory instrumentation
27Media Preparation and Dispensing
CategoryLaboratory instrumentation
28Haemostasis Instrumentation
CategoryLaboratory instrumentation
29Immunohaematology Instrumentation
CategoryLaboratory instrumentation
30Vein Detection System
CategoryLaboratory instrumentation
31Rapid Infuser
CategoryLaboratory instrumentation
32Microarray Platforms
CategoryLaboratory instrumentation
33Hybridization & Immunodot
CategoryLaboratory instrumentation
34microELISA
CategoryLaboratory instrumentation
35Real Time PCR
CategoryLaboratory instrumentation
36CLIA
CategoryLaboratory instrumentation
37Microbiology
CategoryDiagnostics product line (microbiology)
38Infectious Immunology
CategoryDiagnostics product line (microbiology)
39Bacteriology
CategoryDiagnostics product line (microbiology)
40Virology
CategoryDiagnostics product line (microbiology)
41Mycology
CategoryDiagnostics product line (microbiology)
42Parasitology
CategoryDiagnostics product line (microbiology)
43Tuberculosis
CategoryDiagnostics product line (microbiology)
44Cytology
CategoryDiagnostics product line (cytology)
45Liquid Based Cytology
CategoryDiagnostics product line (cytology)
46Molecular Diagnostics
CategoryDiagnostics product line (molecular diagnostics)
47Pathogen Detection
CategoryDiagnostics product line (molecular diagnostics)
48Genetic Abnormalities
CategoryDiagnostics product line (molecular diagnostics)
49Genetic Diseases
CategoryDiagnostics product line (molecular diagnostics)
50Histocompability Molecular Diagnostics
CategoryDiagnostics product line (molecular diagnostics)
51Blood Group Typing
CategoryDiagnostics product line (molecular diagnostics)
52Hormones
CategoryDiagnostics product line (hormones)
53Molecular Testing Services
CategoryLaboratory service
54Immunology
CategoryDiagnostics product line (immunology)
55Autoimmunity
CategoryDiagnostics product line (immunology)
56Immunodeficiency Test
CategoryDiagnostics product line (immunology)
57Histocompability
CategoryDiagnostics product line (immunology)
58External Quality Assessment
CategoryQuality assessment service
59Distribution Network
CategoryDistribution service
60Technical Support
CategoryTechnical support service
Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1ABL Diagnostics
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-10-21
Description

Press release published on 2025-10-21 by einpresswire titled 'ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro', covering new exclusive distribution partnerships in Cyprus and Montenegro. This aligns with VARELAS' own distribution network statement that distribution in Greece and Cyprus is managed from its Kifissia headquarters.

einpresswire.com
2Binding Site
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-04-24
Description

VARELAS S.A. co-hosts and promotes a series of online scientific webinars with Binding Site, presented by Dr. James Last (Head of Medical Scientific Communication at Binding Site). Sessions covered the Freelite kits in multiple myeloma monitoring (24 April 2023), nephrology (26/7/23), serum testing in osteoporosis and bone fractures (25/9/23) and CSF/neurological disorders (27/11/23). The webinars are hosted on VARELAS' 'Διαδικτυακές Εκπαιδύσεις' section with registration links to Binding Site's platform.

varelas.gr
3Galenica Group (ΟΜΙΛΟΣ Galenica)
Strategic tierCoreTypeOthers
Description

VARELAS S.A. is affiliated with the Galenica Group: other companies of the Galenica group provide supporting IT, cloud computing and hosting services with access to VARELAS' information systems and electronic databases. The group also includes the Galenica and Techline sites linked from VARELAS' website navigation.

varelas.gr
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Medochemie GmbH
TypeDirect peer
Description

A Munich-based IVD and laboratory product distributor serving clinical laboratories, hospitals and research institutes across Europe with a broad multi-brand catalogue plus technical support. It is the closest business-model analogue to Varelas' reagent-plus-instrument distribution operation.

2Randox
TypeDirect peer
Description

Northern Ireland-based diagnostics group that supplies IVD reagents and instruments and, crucially, runs its own external quality assessment/proficiency testing schemes across laboratory disciplines. It overlaps directly with Varelas' dual model of product distribution plus EQA programmes.

3Menarini Diagnostics
TypeDirect peer
Description

Italian diagnostics group supplying immunoassay, molecular and specialised testing solutions to clinical laboratories and hospitals with a strong Southern European footprint. Comparable in serving the same hospital-lab customer base with haematology, immunology and molecular product lines.

4Biosystems
TypeDirect peer
Description

Barcelona-based IVD manufacturer and distributor focused on microbiology, haematology and clinical chemistry consumables and reagents. It is directly comparable as a Southern European specialist supplier of laboratory diagnostics into the same hospital and reference-lab channel.

5ABL Diagnostics
TypeEmerging player
Description

Portuguese specialist in molecular diagnostics, blood group genotyping and immunogenetics whose portfolio Varelas distributes exclusively in Cyprus and Montenegro. It intersects directly with Varelas' molecular diagnostics and blood-transfusion product lines while remaining a small, niche manufacturer.

6bioMérieux
TypeBroad incumbent
Description

Global diagnostics incumbent in microbiology (automated blood culture and ID/AST), immunochemistry and molecular detection — precisely the categories Varelas distributes as instrumentation and reagents. It sets the vendor terms, pricing benchmarks and competitive bar that Varelas must sell against.

7Roche Diagnostics
TypeBroad incumbent
Description

World's largest IVD supplier with broad haematology, immunology, molecular and microbiology portfolios sold directly and through distributors in Greece and Cyprus. It is a principal supplier and competitor for the same Greek laboratory budgets.

8Sysmex
TypeBroad incumbent
Description

Haematology and diagnostics incumbent whose analysers (and associated reagents) are sold into Greek and Cypriot laboratories, frequently via local distribution partners. It is directly relevant to Varelas' haematology, immunohaematology and haemostasis instrumentation and reagent lines.

9Beckman Coulter
TypeBroad incumbent
Description

Large laboratory instrumentation and IVD supplier (analysers, centrifuges, automated systems and reagents) selling into the same Greek clinical and research laboratories. It is a broad incumbent competing for the same instrumentation placements that anchor Varelas' consumable pull-through.

10Illumina
TypeOthers
Description

Sequencing platform and consumables supplier whose technology underpins the sequencing services and molecular workflows Varelas offers to Greek research and clinical customers. It is an ecosystem/supplier relationship rather than a like-for-like distributor competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Varelas S.a. Chemicals And Diagnostics

Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distributionvarelas.gr

VARELAS S.A. Chemicals & Diagnostics is a Greece- and Cyprus-based distributor of diagnostics reagents, laboratory instrumentation, life-science research products and laboratory services, supplying hospitals, diagnostic laboratories and research institutions with scientific technical support from its Kifissia headquarters.

What Varelas S.a. Chemicals And Diagnostics does

VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor of diagnostics reagents, life-science research products, laboratory instrumentation and related laboratory services. It serves clinical diagnostics laboratories and hospitals (public and private), diagnostic centres, universities, research institutes and R&D laboratories in Greece and Cyprus. The company was founded in the early 1950s by pharmacist Nikolaos D. Varelas as N.D. VARELAS S.A. Chemicals & Pharmaceuticals, originally distributing and trading medicines, and later repositioned into diagnostics and life-science research supply. It is an unlisted Greek joint-stock company (Α.Ε.) affiliated with the Galenica Group and employs 11-50 people.

The product portfolio is multi-brand and organised by business sector rather than as a single platform, covering haematology (immunohaematology, special blood transfusion tests, haemostasis, plasma cell dyscrasias), immunology and life-science research (autoimmunity, immunodeficiency, histocompatibility/immunogenetics, cytokines and other research molecules, proteins, molecular biology reagents, microarrays, laboratory consumables), microbiology (infectious immunology, bacteriology, virology, mycology, parasitology, tuberculosis), cytology, molecular diagnostics, hormones, and a broad instrumentation catalogue (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, protein electrophoresis, nucleic acid analysis and extraction, media preparation, immunofluorescence, hybridisation/immunodot, microELISA, sample storage systems). Alongside product sales, the company operates laboratory service lines: oligonucleotide synthesis, sequencing, PCR and thermal cycler validation, molecular testing services, and external quality assessment programmes spanning haematology, immunocytochemistry, immunology, histocompatibility/immunogenetics, clinical chemistry, blood transfusion laboratory practice, microbiology and blood coagulation. The technical substrate is in-house service and logistics infrastructure rather than proprietary technology: an Order Entry and Distribution Centre, an Order Entry/Customer Service Centre at the Kifissia headquarters, a Technical Support Department staffed by specialised scientific personnel, and an in-house Order Entry/Customer Service Centre supported by Galenica Group IT, cloud and hosting affiliates.

Revenue is generated through three streams: transaction revenue from distributing diagnostics reagents, kits and consumables; product-sale revenue from laboratory instrumentation; and professional-services revenue from laboratory/technical services and external quality assessment, supported by pre-, during- and post-sales technical support. Pricing is quote-based and not publicly disclosed - no prices, tiers or discounts are published. Go-to-market is primarily direct: order entry by call centre (info@varelas.gr, +30 210 5281900) and the Kifissia distribution centre, inside and field sales into laboratories, hospitals and research institutions, a representative office serving the Northern Greek market from Thessaloniki, and exclusive distribution partnerships (for example, ABL Diagnostics in Cyprus and Montenegro). Demand generation is supported by co-hosted scientific webinars with product partners (a Binding Site Freelite series on multiple myeloma, nephrology, osteoporosis and neurological disorders), online education, a newsletter service and a bilingual corporate website. No revenue figure is disclosed; the only financial document referenced is a FY2015 statutory financial statements PDF (41st corporate year), and no funding rounds, acquisitions, mergers or listing events are disclosed.

Varelas S.a. Chemicals And Diagnostics firmographics

Firmographics
Name
Varelas S.a. Chemicals And Diagnostics
Legal name
VARELAS S.A. Chemicals & Diagnostics (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά)
Website
https://varelas.gr
Company type
Private
Founded year
1950
Operating status
Operating
Headcount range
11–50 employees
Short description
VARELAS S.A. Chemicals & Diagnostics is a Greece- and Cyprus-based distributor of diagnostics reagents, laboratory instrumentation, life-science research products and laboratory services, supplying hospitals, diagnostic laboratories and research institutions with scientific technical support from its Kifissia headquarters.
Ownership category
akta.pro rank

Varelas S.a. Chemicals And Diagnostics industry classification

Industry
Product category
Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distribution
NAICS
Medical and Diagnostic Laboratories (6215), Scientific Research and Development Services (5417)
SIC
Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Services-Medical Laboratories (8071), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAHAAAC
Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
SECONDARYHLAHAAAL
Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Diagnostics reagents distribution
  • Laboratory instrumentation supply
  • Life-science research products
  • External quality assessment programmes
  • Oligonucleotide synthesis services

Where Varelas S.a. Chemicals And Diagnostics is headquartered

Location

Headquarters

HQ city
Kifisiá
HQ country
Greece
HQ region
Europe

Offices2 records

Markets served

Varelas S.a. Chemicals And Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Distribution and sale of diagnostics reagents, kits and consumables: Core revenue comes from supplying and distributing high quality, innovative products (diagnostics reagents, immunohaematology, microbiology, molecular diagnostics, life-science research reagents, laboratory consumables) to the Greek health and life-science research market, generating one-time transaction revenue from order fulfilment through the company's Order Entry and Distribution Centre in Kifissia.
  2. Instrumentation and equipment sales: Sale and supply of laboratory instrumentation (automated blood culture, automated ID/AST, real-time PCR, CLIA, thermal cyclers, turbidimeters/nephelometers, electrophoresis, hybridisation & immunodot, microELISA, sample storage systems) as a product-sale revenue stream.
  3. Laboratory and technical services: Service revenue from oligonucleotide synthesis, sequencing services, PCR/thermal cycler validation, molecular testing services and external quality assessment programmes, complemented by pre-, during- and post-sales technical support delivered by the Technical Support Department.
  4. Pharmaceutical / health product trading (legacy business): Founded in the early 1950s for the distribution and trading of medicines, the company developed rapidly into one of the largest pharmaceutical trading enterprises in Greece; the current entity operates under the Chemicals & Diagnostics name.

Go-to-market motion4 records

Distribution channels3 records

Marketing channels6 records

Varelas S.a. Chemicals And Diagnostics product offering

Product offering

Core offering

VARELAS S.A. is a Greek distributor of diagnostics reagents and kits (haematology, immunohaematology, haemostasis, microbiology, cytology, molecular diagnostics, hormones, life-science research reagents) and laboratory instrumentation, together with related laboratory services including oligonucleotide synthesis, sequencing, PCR/thermal cycler validation, molecular testing and external quality assessment programmes. Products are sourced from third-party manufacturers and supplied to clinical diagnostics laboratories, hospitals and life-science research institutions across Greece and Cyprus through its own Order Entry and Distribution Centre in Kifissia, backed by a scientific technical support department.

Product overview

VARELAS S.A. (ΒΑΡΕΛΑΣ Α.Ε. Χημικά & Διαγνωστικά) is a Greek distributor — not a single unified software product — whose offering is a multi-brand, multi-sector portfolio of diagnostics reagents, life-science research products, laboratory instrumentation and related services, delivered to Greek and Cypriot health and research markets. The portfolio is organised as business-sector product lines rather than a core platform with add-on modules: Haematology (Immunohaematology, Special Blood Transfusion Tests, Haemostasis, Plasma Cell Dyscrasias), Life Science Research (Molecular Biology Reagents, Laboratory Consumables, Cytokines & Other Research Molecules, Microarrays, Oligonucleotide Synthesis Services, Sequencing Services, Sample Storage and Management Systems, PCR Validation), Instrumentation (Nucleic Acid Analysis, Immunodiffusion, Immunofluorescence, Hyperthermia Pump, Gel Documentation, Nucleic Acid Extraction, Automated Blood Culture Systems, Automated ID/AST Systems, Blood Transfusion Lab Instrumentation, Proteins Electrophoresis, Thermal Cyclers, Turbidimeters/Nephelometers, Media Preparation and Dispensing, Haemostasis and Immunohaematology Instrumentation, Vein Detection System, Rapid Infuser, Microarray Platforms, Hybridization & Immunodot, microELISA, Real Time PCR, CLIA), Microbiology (Infectious Immunology, Bacteriology, Virology, Mycology, Parasitology, Tuberculosis), Cytology (Liquid Based Cytology), Molecular Diagnostics (Pathogen Detection, Genetic Abnormalities, Genetic Diseases, Histocompability, Blood Group Typing), Hormones, Molecular Testing Services, Immunology (Autoimmunity, Immunodeficiency Test, Histocompability, Cytokines & Other Research Molecules, Proteins) and External Quality Assessment programmes. These sector lines are complemented by service layers — the Distribution Network and Technical Support functions and an online webinar training series (with Binding Site, featuring the Freelite free light chain kits for multiple myeloma monitoring) — so instrumentation, reagents and consumables are sold together with logistics, training and quality-assessment support rather than as one connected software platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • Immunohaematology
  • Special Blood Transfusion Tests
  • Haemostasis
  • Plasma Cell Dyscrasias
  • Molecular Biology Reagents
  • Laboratory Consumables
  • Cytokines & Other Research Molecules
  • Proteins
  • Microarrays
  • Oligonucleotide Synthesis Services
  • Sequencing Services
  • Sample Storage and Management Systems
  • PCR Validation
  • Thermal Cycler Validation
  • Nucleic Acid Analysis
  • Immunodiffusion
  • Immunofluorescence
  • Hyperthermia Pump
  • Gel Documentation
  • Nucleic Acid Extraction
  • Automated Blood Culture Systems
  • Automated ID/AST Systems
  • Blood Transfusion Lab Instrumentation
  • Proteins Electrophoresis
  • Thermal Cyclers
  • Turbidimeters / Nephelometers
  • Media Preparation and Dispensing
  • Haemostasis Instrumentation
  • Immunohaematology Instrumentation
  • Vein Detection System
  • Rapid Infuser
  • Microarray Platforms
  • Hybridization & Immunodot
  • microELISA
  • Real Time PCR
  • CLIA
  • Microbiology
  • Infectious Immunology
  • Bacteriology
  • Virology
  • Mycology
  • Parasitology
  • Tuberculosis
  • Cytology
  • Liquid Based Cytology
  • Molecular Diagnostics
  • Pathogen Detection
  • Genetic Abnormalities
  • Genetic Diseases
  • Histocompability Molecular Diagnostics
  • Blood Group Typing
  • Hormones
  • Molecular Testing Services
  • Immunology
  • Autoimmunity
  • Immunodeficiency Test
  • Histocompability
  • External Quality Assessment
  • Distribution Network
  • Technical Support

Quantifiable outcome

  • Operations spanning more than four decades of continuous development of the Greek health and life-science research market
  • +1 more outcomes

Companies that use Varelas S.a. Chemicals And Diagnostics

Customer profile

Segments5 records

Ideal customer profiles4 records

Varelas S.a. Chemicals And Diagnostics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Varelas S.a. Chemicals And Diagnostics partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • ABL DiagnosticscoreChannel Partner/ Reseller/ Distributor · 21 October 2025Press release published on 2025-10-21 by einpresswire titled 'ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro', covering new exclusive distribution partnerships in Cyprus and Montenegro. This aligns with VARELAS' own distribution network statement that distribution in Greece and Cyprus is managed from its Kifissia headquarters.
  • Binding SitecoreTechnology or Integration · 24 April 2023VARELAS S.A. co-hosts and promotes a series of online scientific webinars with Binding Site, presented by Dr. James Last (Head of Medical Scientific Communication at Binding Site). Sessions covered the Freelite kits in multiple myeloma monitoring (24 April 2023), nephrology (26/7/23), serum testing in osteoporosis and bone fractures (25/9/23) and CSF/neurological disorders (27/11/23). The webinars are hosted on VARELAS' 'Διαδικτυακές Εκπαιδύσεις' section with registration links to Binding Site's platform.
  • Galenica Group (ΟΜΙΛΟΣ Galenica)coreOthersVARELAS S.A. is affiliated with the Galenica Group: other companies of the Galenica group provide supporting IT, cloud computing and hosting services with access to VARELAS' information systems and electronic databases. The group also includes the Galenica and Techline sites linked from VARELAS' website navigation.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Varelas S.a. Chemicals And Diagnostics competitors and assessment

Company assessment

Direct peers

  • Medochemie GmbH: A Munich-based IVD and laboratory product distributor serving clinical laboratories, hospitals and research institutes across Europe with a broad multi-brand catalogue plus technical support. It is the closest business-model analogue to Varelas' reagent-plus-instrument distribution operation.
  • Randox: Northern Ireland-based diagnostics group that supplies IVD reagents and instruments and, crucially, runs its own external quality assessment/proficiency testing schemes across laboratory disciplines. It overlaps directly with Varelas' dual model of product distribution plus EQA programmes.
  • Menarini Diagnostics: Italian diagnostics group supplying immunoassay, molecular and specialised testing solutions to clinical laboratories and hospitals with a strong Southern European footprint. Comparable in serving the same hospital-lab customer base with haematology, immunology and molecular product lines.
  • Biosystems: Barcelona-based IVD manufacturer and distributor focused on microbiology, haematology and clinical chemistry consumables and reagents. It is directly comparable as a Southern European specialist supplier of laboratory diagnostics into the same hospital and reference-lab channel.

Emerging players

  • ABL Diagnostics: Portuguese specialist in molecular diagnostics, blood group genotyping and immunogenetics whose portfolio Varelas distributes exclusively in Cyprus and Montenegro. It intersects directly with Varelas' molecular diagnostics and blood-transfusion product lines while remaining a small, niche manufacturer.

Broad incumbents

  • bioMérieux: Global diagnostics incumbent in microbiology (automated blood culture and ID/AST), immunochemistry and molecular detection — precisely the categories Varelas distributes as instrumentation and reagents. It sets the vendor terms, pricing benchmarks and competitive bar that Varelas must sell against.
  • Roche Diagnostics: World's largest IVD supplier with broad haematology, immunology, molecular and microbiology portfolios sold directly and through distributors in Greece and Cyprus. It is a principal supplier and competitor for the same Greek laboratory budgets.
  • Sysmex: Haematology and diagnostics incumbent whose analysers (and associated reagents) are sold into Greek and Cypriot laboratories, frequently via local distribution partners. It is directly relevant to Varelas' haematology, immunohaematology and haemostasis instrumentation and reagent lines.
  • Beckman Coulter: Large laboratory instrumentation and IVD supplier (analysers, centrifuges, automated systems and reagents) selling into the same Greek clinical and research laboratories. It is a broad incumbent competing for the same instrumentation placements that anchor Varelas' consumable pull-through.

Others

  • Illumina: Sequencing platform and consumables supplier whose technology underpins the sequencing services and molecular workflows Varelas offers to Greek research and clinical customers. It is an ecosystem/supplier relationship rather than a like-for-like distributor competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Varelas S.a. Chemicals And Diagnostics social profiles

Digital presence

Varelas S.a. Chemicals And Diagnostics compliance and trust

Trust signal

Compliance4 records

Varelas S.a. Chemicals And Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Varelas S.a. Chemicals And Diagnostics leadership team

Management profile

Number of profiles

Varelas S.a. Chemicals And Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Varelas S.a. Chemicals And Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Varelas S.a. Chemicals And Diagnostics

What does Varelas S.a. Chemicals And Diagnostics do?

VARELAS S.A. is a Greek distributor of diagnostics reagents and kits (haematology, immunohaematology, haemostasis, microbiology, cytology, molecular diagnostics, hormones, life-science research reagents) and laboratory instrumentation, together with related laboratory services including oligonucleotide synthesis, sequencing, PCR/thermal cycler validation, molecular testing and external quality assessment programmes. Products are sourced from third-party manufacturers and supplied to clinical diagnostics laboratories, hospitals and life-science research institutions across Greece and Cyprus through its own Order Entry and Distribution Centre in Kifissia, backed by a scientific technical support department.

Is Varelas S.a. Chemicals And Diagnostics a public or private company?

Varelas S.a. Chemicals And Diagnostics is a private company. It is classified as family owned and is currently operating.

When was Varelas S.a. Chemicals And Diagnostics founded?

Varelas S.a. Chemicals And Diagnostics was founded in 1950. It employs 11 to 50 people.

Where is Varelas S.a. Chemicals And Diagnostics based?

Varelas S.a. Chemicals And Diagnostics is headquartered in Kifisiá, Greece, in the Europe region.

How does Varelas S.a. Chemicals And Diagnostics make money?

Four revenue lines are on record. Distribution and sale of diagnostics reagents, kits and consumables are the primary driver. The others are instrumentation and equipment sales, laboratory and technical services and pharmaceutical / health product trading (legacy business).

Who are Varelas S.a. Chemicals And Diagnostics's main competitors?

Direct peers on record are Medochemie GmbH, Randox, Menarini Diagnostics and Biosystems. ABL Diagnostics is listed as an emerging player. Broad incumbents are bioMérieux, Roche Diagnostics, Sysmex and Beckman Coulter. Illumina is listed as an others.

Does Varelas S.a. Chemicals And Diagnostics have an API?

No public API is recorded for Varelas S.a. Chemicals And Diagnostics.

What industry is Varelas S.a. Chemicals And Diagnostics in?

Varelas S.a. Chemicals And Diagnostics's product category is Diagnostics Reagents, Laboratory Instrumentation and Life-Science Supply Distribution. Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 6215 and its SIC code is 5047.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales